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Black and White Adult Family Members’ Attitudes Toward
a Dementia Diagnosis
Cathleen M Connell, PhD, J. Scott Roberts, PhD, Sara J. McLaughlin, PhD, and
Brian D. Carpenter, PhDw
OBJECTIVES: To examine potential benefits of and bar-
riers to diagnosis from the perspective of black and white
adults directly affected by Alzheimer’s disease (AD).
DESIGN: Telephone survey.
SETTING: Convenience sample recruited from two U.S.
metropolitan areas.
PARTICIPANTS: One hundred seventy-eight family mem-
bers of people with AD, including current and former AD
caregivers and immediate blood relatives of someone with
AD.
MEASUREMENTS: Respondents were asked to rate the
importance of eight benefits of and 16 barriers to obtaining
a diagnosis.
RESULTS: Family members strongly endorse several ben-
efits of obtaining a diagnosis, including getting information,
finding out what is wrong with their relative, and prompt-
ing future planning. A majority of survey respondents did
not endorse any barriers examined. Lack of a cure for AD
and the belief that little can be done for someone with AD
were the most frequently endorsed barriers. Black respon-
dents endorsed five of the eight benefits more frequently
than white respondents.
CONCLUSION: Black and white adults with a family
member who has received an diagnosis of AD perceive a
range of benefits and few barriers to the diagnostic process
examined in this study. Their positive experiences might be
instructive to families considering pursuing a diagnosis and
to physicians who may be reluctant to offer screening or
referral because of the belief that families have little to gain.
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With the aging of the population and the correspondingincrease in prevalence of Alzheimer’s disease (AD),1
knowledge and awareness of the disease among the general
public, family caregivers, and first-degree relatives have
been reported to be high.2–6 However, diagnosis of AD is
typically delayed until several years into the course of the
disease,7,8 despite an increasing awareness of the benefits of
more-timely recognition of and response to the early symp-
toms of the disease.9,10 Some of the reported benefits of
obtaining a diagnosis include reducing uncertainty for the
patient and family members, increasing access to and the
efficacy of available medications, providing opportunities
for patient involvement in planning for the future and
making decisions about care and research participation,
receiving referrals and access to supportive services and
programs, and providing enhanced safety and security.11
Despite growing attention to and debate about the
identification of mild cognitive impairment and early-stage
AD in the research community,12,13 little is known about
how family members decide whether and when to seek help
after first noticing symptoms of dementia in a loved one. In
most of the handful of relevant studies, family members are
asked to reflect on their past experiences with a dementia
diagnosis. One such study14 reported that of spouse care-
givers, most endorsed a number of benefits of obtaining a
diagnosis, including finding out what is wrong with their
spouse and excluding other causes of memory or behavior
problems. Several obstacles to obtaining a diagnosis were
also reported, including the belief that the process is time
consuming and expensive, a diagnosis is unnecessary, be-
cause there is no cure or treatment for AD, and memory
problems are part of normal aging.14 Based on focus group
interviews, one study discovered that one of the major ben-
efits of obtaining a diagnosis that caregivers reported was
that it helped them to be more patient with and under-
standing of their ill family member and enabled them to
make more-informed decisions on their behalf.15 In a sam-
ple of adults with early-stage dementia, a diagnosis pro-
vided a sense of relief, because it offered an explanation for
their symptoms and marked the initiation of a treatment
plan.16
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Because family members are largely responsible for
making decisions on behalf of those affected by AD, their
knowledge, attitudes, and beliefs regarding assessment and
treatment options are critical to an understanding of who
gets diagnosed and the circumstances that prompt help-
seeking. If, for example, family members believe that mem-
ory loss is an inevitable sign of aging, they may be unlikely
to bring symptoms to the attention of a healthcare provider.
Similarly, symptoms of dementia may be attributed to other
causes, such as coexisting illnesses, a mental health condi-
tion, or stress. Although the general public is fairly knowl-
edgeable about the disease,2 notable differences in AD
knowledge, beliefs, and experiences have been documented
between groups defined according to race and ethnicity.17–19
In a nationwide study, for example, black and Hispanic re-
spondents were significantly more likely than white adults to
view memory loss as an expected part of aging while also
being more optimistic about prospects for finding a cure
through continued research.2 These findings were consistent
with those reported in a recent study that included family
caregivers and first-degree relatives of people with AD.3
Specifically, blacks were significantly more likely than
whites to believe that memory loss is an expected part of
aging while being more optimistic about the current and
future state of AD diagnosis, treatment, and research. Over-
all knowledge about AD and concern about the disease was
lower in black than white respondents.3
Finally, one of the few studies that examined cross-
ethnic differences in dementia caregivers’ retrospective ac-
counts of their experience with obtaining a diagnosis found
that black families were less likely than white families to
take a ‘‘smooth pathway’’ to diagnosis.7 A smooth pathway
was defined as starting with recognition of symptoms, fol-
lowed by active help-seeking from a physician, and com-
pleted by diagnosis in primary care or by a referred
specialist. Instead of this smooth pathway, black dementia
caregivers were more likely than whites to have initiated
help-seeking in response to a crisis, often when an ongoing
behavioral problem became severe.
These and other racial and cultural differences in AD
knowledge and beliefs and in issues related to caregiving
and help-seeking probably affect attitudes toward obtain-
ing a dementia diagnosis.20–24 Combined with estimates
that AD prevalence may be higher for blacks than whites25
and evidence that delays in diagnosis are particularly com-
mon in blacks, who may face unique barriers to care and
seek care at a later point in the disease process than
whites,7,26,27 further examination of racial differences in
attitudes toward diagnosis is warranted. The primary pur-
pose of the present study was to examine potential benefits
of and barriers to diagnosis from the perspective of black
and white adults directly affected by AD; a secondary
purpose was to explore black–white differences in these
perceptions.
METHODS
The Treatment and Illness Perceptions Survey
The Treatment and Illness Perceptions Survey (TIPS) was
originally developed to examine attitudes, beliefs, and ex-
periences regarding AD in a sample of first-degree rela-
tives.28 Scales assessing domains such as perceived threat of
AD, perceived causes of AD, and treatment beliefs all per-
formed with very good to excellent reliability.29 The current
version of the survey was designed to examine knowledge
about AD and symptoms, information sources about AD,
perceptions of the effectiveness of various AD treatments,
risk perceptions about AD, and attitudes about genetic
testing for AD. Results pertaining to knowledge and beliefs
about AD have been published separately.3
The survey was administered to a sample of adults with
varying exposure to AD, including first-degree relatives
(adult children and siblings) of people with AD (living
or deceased), current and former primary caregivers of
people with AD, and those with neither an affected first-
degree relative nor an AD caregiving history. Presence of
AD in the affected family member was assessed according
to self-report. Potential participants who demonstrated an
inability to understand and respond to the survey items be-
cause of cognitive impairment or lack of fluency in English
were excluded from this study.
Using multiple strategies (e.g., newspaper advertise-
ments, physician referral) and sources (e.g., community
health fairs, university-affiliated AD research center), 301
adults (141 black; 160 white) residing in the Boston and
Atlanta metropolitan areas were recruited for participation.
Eleven individuals who reported ‘‘other’’ race or ethnicity
were excluded because of their small subsample size. Par-
ticipants were contacted by telephone; interviews averaged
30 minutes in length.
Measures
A subsample of the larger group of TIPS respondents who
indicated that they have or had a family member with AD
were asked about potential benefits of and barriers to ob-
taining a diagnosis of AD using the same items described in
previous work.14 Specifically, participants were asked to
rate the importance (1 5 not important, 2 5 somewhat im-
portant, 3 5 moderately important, 4 5 very important,
5 5 extremely important) of eight possible benefits of ob-
taining a diagnosis: let me know what was wrong with my
relative, allowed me to plan for the future, allowed me to
involve my relative in important decisions (e.g., making a
will), allowed me to obtain information about AD, may
qualify my relative for drug treatment, was helpful to my
family in case AD is hereditary, allowed me to exclude other
causes of memory or behavior problems, and allowed me to
use appropriate community services.
As a transition to the next section of the survey, the
interviewer read the following statement: ‘‘Some family
members have identified obstacles to getting a diagnosis of
AD. I will now ask you to indicate the extent to which you
agree with the following statements.’’ Respondents were
asked to rate the degree to which they agreed (1 5 strongly
disagree, 2 5 somewhat disagree, 3 5 neutral, 4 5 some-
what agree, 5 5 strongly agree) with each of 16 potential
barriers to obtaining a diagnosis of dementia: my family
physician did not make a referral to a specialist, there are so
few physicians trained to diagnose dementia in my local
area, the process was so time consuming, the process was
so expensive, the process was not covered by our health
insurance, my family members did not agree that it was
important, my relative was not willing to be tested, it is very
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demanding for the patient, it is very demanding for the
family, so little can be done for people with AD, memory
problems are part of the normal aging process, there is no
cure for AD, there is no effective treatment for AD, there is a
stigma against people with AD, it is easier not to know what
the diagnosis is, and it would require seeing a specialist
instead of a family physician.
Data Analysis
Of the 301 respondents, 222 reported having a living or
deceased family member with AD. Forty of the 222 re-
spondents were missing key outcome data, and four par-
ticipants were excluded from this analysis because of data
inconsistencies (e.g., first reporting having a family member
with AD but later responding ‘‘0’’ when asked about the
number of affected family members). Thus, the analytical
sample consisted of 178 respondents. The 40 respondents
with missing data were significantly more likely to be black
and significantly less likely to have ever been a caregiver for
someone with AD. No significant differences (related to
missing data status) were evident according to age, sex,
education, or marital status (P4.05).
For this investigation, the percentage of adults rating
each benefit as very or extremely important and strongly
agreeing with each barrier to diagnosis was examined over-
all and according to race. Response options were collapsed
in this way (i.e., very/extremely important vs all others and
strongly agree vs all others) to permit comparison between
respondents who unambiguously endorsed the items and all
others.
Racial differences in response were first examined using
chi-square tests. To determine whether any observed differ-
ences were significant after adjusting for racial differences in
caregiver status, education, marital status, and month-end
financial status (all significant at Po.10), multivariate logistic
regression analyses were conducted. In a series of regression
models, responses to each benefit and barrier were regressed
on caregiver status (1 5 current or former caregiver to some-
one with AD; 0 5 not a current or former caregiver), educa-
tion (1 5 high school or less, 0 5 greater than high school),
marital status (1 5 married, 0 5 not married), month-end
financial status (1 5 end up with money left over, 0 5 no
money left over), and race (1 5 black, 0 5 white).
RESULTS
Sample Characteristics
The median age of the sample was 57 (range 27–81).
Women constituted 82.0% of the sample, 57.9% of re-
spondents were white, 77.0% participants reported having
more than a high school education, 57.9% of the sample
was married, and 59.6% reported having money left over at
the end of the month. A significantly lower percentage of
black respondents than of white respondents reported being
married (42.7% vs 68.9%) and having more than a high
school education (61.3% vs 88.4%). A higher percentage of
black than white respondents reported being a current or
former caregiver to someone with AD (80.0% vs 55.3%).
No significant racial differences were observed for age, sex,
or financial status (Po.05) (Table 1).
The family member with AD was the mother of 53.4%
of the survey respondents. Other affected family members
were father (20.8%), spouse (15.7%), aunt or uncle (14.6%),
grandparent (14.0%), sister (4.5), brother (3.9%), and some
other relative (20.8%). Because respondents were able to re-
port having or having had more than one family member
with AD, the types of family members affected do not sum
to 100%.
Benefits of Obtaining a Diagnosis
Respondents endorsed a median of six benefits (range 5 0–
8; data not shown). Three-quarters or more of the sample
rated three of the eight potential benefits of obtaining a
diagnosis as very or extremely important: learning what
was wrong with their family member, the ability to make
future plans, and obtaining information about the disease
(Table 2). In addition, more than 60% of the sample re-
ported that receiving a diagnosis might ‘‘qualify [their]
relative for drug treatment’’ and allow them to use com-
munity services. Similar percentages endorsed that knowing
the diagnosis was ‘‘helpful to [their] family in case AD is
hereditary’’ and that it allowed them to eliminate other po-
tential causes of their family members’ symptoms. Just over

















o57 49.7 46.0 52.4 0.72 .39
57 50.3 54.1 47.6
Current or former caregiver to someone with Alzheimer’s disease
Yes 65.7 80.0 55.3 11.72 o.001
No 34.3 20.0 44.7
Education
High school 23.0 38.7 11.7 17.87 o.001
4High school 77.0 61.3 88.4
Sex
Male 18.0 16.0 19.4 0.34 .56
Female 82.0 84.0 80.6
Marital status
Married 57.9 42.7 68.9 12.28 o.001










Black 42.1 F F F F
White 57.9
Percentages may sum to slightly more than 100 due to rounding.
Median age 5 57 (range 27–81).
wMissing one data point.
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half the sample (57.9%) viewed ‘‘[involving their] relative
in important decisions (making a will)’’ as an important
benefit of obtaining a diagnosis.
In the unadjusted analysis, significant racial differences
in perceived benefits were evident for five of the eight ben-
efits: ‘‘let me know what was wrong with my relative,’’ ‘‘al-
lowed me to involve my relative in important decisions
(making a will),’’ ‘‘may qualify my relative for drug treat-
ment,’’ ‘‘was helpful to my family in case AD is hereditary,’’
and ‘‘allowed me to use appropriate community services.’’
In all cases, a higher percentage of black than white re-
spondents rated these benefits as very or extremely impor-
tant (Table 2). After controlling for differences in caregiver
status, education, finances, and marital status, racial differ-
ences remained significant, with black respondents having
more than two times the odds of endorsing these benefits as
very or extremely important as their white counterparts
(Table 3).
Barriers to Obtaining a Diagnosis
Respondents endorsed a median of two barriers (range 5 0–
13; data not shown). As shown in Table 4, a majority of the
sample did not endorse any single barrier. The percentage of
respondents strongly endorsing each of the 16 barriers
ranged from 6.2%, for ‘‘it is easier not to know what the
diagnosis is,’’ to 36.0%, for ‘‘there is no cure for AD.’’
Nevertheless, more than one-quarter of the sample en-
dorsed three treatment-related barriers: the perception that
‘‘so little can be done for people with AD,’’ the lack of a
cure for the disease, and the belief that ‘‘there is no effec-
tive treatment for AD.’’ Moreover, roughly one-quarter of
the sample strongly agreed that obtaining a diagnosis of
dementia is ‘‘very demanding for the family,’’ and 20.8%
of the sample endorsed ‘‘there are so few physicians trained
to diagnose dementia in my local area.’’
In the unadjusted analysis, significant racial differences
were evident for five of the 16 barriers (Table 4). A lower
percentage of black than white respondents endorsed two
of the aforementioned treatment-related barriers (no cure
and no effective AD treatment). In contrast, blacks en-
dorsed three access-related barriers more frequently than
whites: ‘‘there are so few physicians trained to diagnose
dementia in my local area,’’ ‘‘the process was so expensive,’’
and ‘‘our health insurance did not cover the process.’’ After
adjustment for covariates, only the treatment-related bar-
riers remained significantly different for blacks and whites.
The odds of black respondents strongly agreeing that
these factors made obtaining a diagnosis of dementia diffi-
cult were approximately 50% to 75% lower than for white
respondents (Table 5).
DISCUSSION
Understanding how families decide whether and when to
obtain a dementia diagnosis is timely, given the growing
awareness of the benefits of early diagnosis and the avail-
ability and efficacy of new treatments. Results suggest that,
on the whole, family members affected by AD endorsed a
wide range of the benefits but few of the barriers to ob-
taining a diagnosis examined in this study. The most fre-
quently endorsed benefits pertained to obtaining
information, finding out what was wrong, and prompting
future plans. In addition to the lack of a cure for AD, the
beliefs that little can be done for someone with AD, that
there is a lack of effective treatment, and that obtaining a
diagnosis was a demanding process for families were the
barriers most frequently endorsed.
Table 2. Participants Rating Each Potential Benefit of Obtaining a Diagnosis of Alzheimer’s Disease (AD) as Very or











Let me know what was wrong with my relative 78.1 89.3 69.9 9.58 .002
Allowed me to plan for the future 75.3 80.0 71.8 1.55 .21
Allowed me to involve my relative in important decisions (making a will) 57.9 76.0 44.7 17.48 o.001
Allowed me to get information about AD 80.9 85.3 77.7 1.65 .20
May qualify my relative for drug treatment 63.5 74.7 55.3 6.99 .008
Was helpful to my family in case AD is hereditary 63.5 77.3 53.4 10.73 .001
Allowed me to rule out other causes of memory or behavior problems 67.4 68.0 67.0 .02 .89
Allowed me to use appropriate community services 67.4 78.7 59.2 7.47 .006
Table 3. Benefits of a Diagnosis of Alzheimer’s Disease





Let me know what was wrong with my
relative
3.47 (1.32–9.17) .01
Allowed me to plan for the future 1.90 (0.81–4.45) .14
Allowed me to involve my relative in
important decisions (making a will)
4.48 (2.02–9.93) o.001
Allowed me to get information about AD 1.38 (0.57–3.32) .48
May qualify my relative for drug treatment 2.60 (1.24–5.46) .01
Was helpful to my family in case AD is
hereditary
3.36 (1.57–7.18) .002
Allowed me to rule out other causes of
memory or behavior problems
0.97 (0.47–2.00) .93
Allowed me to use appropriate community
services
2.15 (1.01–4.58) .048
Adjusted for caregiver status, education, finances, and marital status.
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This pattern of results is consistent with that reported
in a previous survey of spouse caregivers that addressed the
same benefits of and barriers to diagnosis.14 However, in
that study, the benefits of and barriers to diagnosis were
more frequently endorsed than in the present sample. These
differences may be related to differences in sample compo-
sition (e.g., spouse caregivers currently living with the care
recipient in the case of the earlier study; family members of
a current or deceased family member with AD in the present
study).
To address the second objective of this study, racial
differences in perceived barriers and benefits to diagnosis
were examined for two primary reasons; specifically, recent
research suggests that knowledge and attitudes about AD
and the timing of help-seeking once symptoms are recog-
nized varies according to race. In the current study, racial
differences in perceived benefits of diagnosis were notable.
Black respondents endorsed five of the eight benefits more
frequently than white respondents after controlling for de-
mographic variables. Three of these benefits involved ob-
taining information for the family (finding out what was
wrong, involving their family member in decision-making,
letting the family know in case AD is hereditary); the other
two benefits pertained to access to treatment and commu-
nity services.
Roughly one-quarter or more of the sample unambig-
uously endorsed only four of the 16 barriers examined;
three were treatment-related barriers (no cure, no effective
treatment, little can be done for someone with AD) and
the fourth pertained to the demand that the diagnostic
process places on the family of the affected individual.
In adjusted analyses, black respondents were significantly
less likely to endorse two of the three treatment-related
barriers than their white counterparts: ‘‘there is no effective
treatment for AD’’ and ‘‘there is no cure for AD.’’ This
finding is consistent with the high level of optimism about
future advances in research shown by blacks in another
recent study.2














My family physician did not make a referral to a specialist. 19.1 22.7 16.5 1.07 .30
There are so few physicians trained to diagnose dementia in my local area. 20.8 28.0 15.5 4.10 .04
The process was so time consuming. 12.4 17.3 8.7 2.96 .08
The process was so expensive. 10.7 16.0 6.8 3.86 .05
Health insurance did not cover the process. 12.4 18.7 7.8 4.76 .03
My family members did not agree that it was important. 6.7 6.7 6.8 .00 .97
My relative was not willing to be tested. 12.9 8.0 16.5 2.79 .09
It is very demanding for the patient. 17.4 20.0 15.5 0.60 .44
It is very demanding for the family. 24.7 24.0 25.2 0.04 .85
So little can be done for people with AD. 29.8 22.7 35.0 3.13 .08
Memory problems are part of the normal aging process. 8.4 12.0 5.8 2.14 .14
There is no cure for AD. 36.0 24.0 44.7 8.04 .005
There is no effective treatment for AD. 25.8 14.7 34.0 8.45 .004
There is a stigma against people with AD. 17.4 18.7 16.5 0.14 .71
It is easier not to know what the diagnosis is. 6.2 6.7 5.8 F 1.00
It would require seeing a specialist instead of a family physician. 6.7 8.0 5.8 0.33 .57
Fisher exact test.
Table 5. Barriers to Diagnosis of Alzheimer’s Disease







My family physician did not make a
referral to a specialist.
1.29 (0.55–3.03) .57
There are so few physicians trained to
diagnose dementia in my local area.
1.86 (0.80–4.29) .15
The process was so time consuming. 2.45 (0.87–6.88) .09
The process was so expensive. 2.53 (0.75–8.54) .13
The process was not covered by our
health insurance.
1.52 (0.50–4.59) .46
My family members did not agree that it
was important.
0.89 (0.23–3.49) .87
My relative was not willing to be tested. 0.52 (0.17–1.60) .26
It is very demanding for the patient. 1.37 (0.56–3.38) .49
It is very demanding for the family. 1.00 (0.44–2.27) 1.00
So little can be done for people with AD. 0.50 (0.23–1.10) .08
Memory problems are part of the normal
aging process.
2.66 (0.70–10.08) .15
There is no cure for AD. 0.46 (0.22–0.98) .04
There is no effective treatment for AD. 0.23 (0.09–0.57) .002
There is a stigma against people with AD. 1.43 (0.58–3.55) .44
It is easier not to know what the
diagnosis is.
0.94 (0.23–3.84) .93
It would require seeing a specialist
instead of a family physician.
0.90 (0.21–3.83) .89
Adjusted for caregiver status, education, finances, and marital status.
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To summarize the racial differences in findings, it is
notable and encouraging that black respondents expressed
more-positive views of obtaining a diagnosis than their
white counterparts, especially in light of the consistent
health disparities that have been identified in awareness of
and response to illness. Not only were black respondents
more likely to strongly endorse a number of benefits, but
they were also less likely to view the fact that there is cur-
rently no cure or effective treatment as a barrier to diag-
nosis. Although it is difficult to interpret these findings, it
could be that black respondents held lower expectations
for their help-seeking experience than white respondents.
Their positive views, then, may reflect the fact that their
experience in obtaining a diagnosis (and possibly receiving
follow-up care and referrals) was more worthwhile than
they expected it to be, leading to a stronger endorsement of
benefits than by their white counterparts. Another possible
explanation for the particularly positive views about diag-
nosis expressed by black respondents in this study might
be related to their perceptions of AD. For example, to the
extent that blacks view AD as part of normal aging and as
‘‘God’s will,’’3 obtaining a diagnosis could be viewed as a
necessary step in the process of accepting the illness, as
opposed to a dreaded and definitive event. As described
previously,30 future work should move beyond simply
quantifying racial differences and begin to explore the cul-
tural dynamics behind observed differences by taking into
account region, language, religion, quality of education,
literacy, acculturation, and wealth.
Although this study expands understanding of attitudes
toward diagnosis, several study limitations should be noted.
First, the sample was primarily female and reported a
higher than average educational level. Second, these results
should be viewed as preliminary because they are based on
small subgroup sample sizes. In addition, all study partic-
ipants had a living or deceased family member who had
received a diagnosis of AD; beliefs of those who chose
not (or could not) obtain a diagnosis were not assessed.
Nevertheless, this study reflects the views of those who have
received a diagnosis, and as such, results may be useful
to family members who are considering what to do next
once symptoms of dementia are recognized in a family
member.
Furthermore, although a wide array of benefits and
barriers that have been identified in previous research were
assessed, there are probably additional factors that were
omitted, some of which may be particularly influential in
decision-making of minority families. For example, a di-
verse sample of older adults mentioned two barriers to
seeking memory screening that were not included in this
study: the fear that a diagnosis might result in healthcare
discrimination or in losing a driver’s license.31 The percep-
tion of covert racism or cultural insensitivity on the part of
some healthcare professionals may also serve as a barrier
for families considering seeking needed services, including a
diagnosis.32 Finally, black families may be less likely to seek
help because of the strong belief that it is their sole respon-
sibility to care for a relative with dementia with only limited
outside help.20,26,32 These broader and possibly culturally
specific factors should be included in future research on
family decision-making about help-seeking related to pur-
suing a diagnosis.
It is also important to acknowledge that perceptions
about the benefits and barriers of a diagnosis were gathered
retrospectively. With time, family members may forget de-
tails about the experience, and their views about obtaining
a diagnosis may change with the progression of the disease.
Because time since diagnosis was not assessed, the effect of
time on attitudes as measured in this study could not be
examined.
Future research in this area should involve a larger and
more diverse and representative sample. Inclusion of two
groupsFfamilies who are yet undecided about pursuing a
diagnosis and those who have chosen not to do soFwould
provide an important compliment to the present study.
Learning more from these groups might also help to identify
unique benefits and barriers to diagnosis that may differ
according to race and help to explain why blacks may ex-
perience longer delays between symptom recognition and
diagnosis than whites. It would also be informative to ask
those who are currently experiencing mild cognitive im-
pairment to reflect on their views about further testing and
diagnosis, because the perspective of the individual affected
by AD is often lost in dementia research.33 Finally, to de-
termine whether educational outreach efforts designed to
increase public awareness of AD and the benefits of early
diagnosis are having the desired effect, longitudinal re-
search is needed to assess change over time in attitudes and
beliefs.
Touting the benefits of obtaining a diagnosis, partic-
ularly one viewed as ‘‘early,’’ may be an easy task for
advocacy organizations, the research community, and
healthcare providers. Convincing an adult child or
spouse to undergo the steps necessary to obtain a com-
prehensive diagnosis for a family member is quite an-
other.34 Results of this study suggest that black and white
family members who have received a diagnosis perceive a
number of benefits of having done so while endorsing
few of the barriers examined in this study. These results
are encouraging and suggest that efforts to raise disease
awareness and improve access to dementia care and
treatment may prove fruitful, because family members
are not inherently averse to the diagnostic process itself.
To the extent that the positive experiences of those who
have been through the process can be directly shared
through educational outreach, more families may con-
sider pursuing a diagnosis and participating in research if
the option is presented in a tailored and culturally ap-
propriate manner. For example, findings from the current
study suggest that family-related benefits might be espe-
cially salient for black families. An educational campaign
from a trusted source, such as the National Alzheimer’s
Association, that incorporates personal testimonials
from family members who have experienced the diag-
nostic process may be particularly likely to inspire help-
seeking. Results might also be informative to primary
care physicians who may be reluctant to offer screening
and referral for a comprehensive diagnosis because of
concerns that families may not realize significant benefits
or encounter negative consequences33,35,36 Knowing that
family members are generally relieved to have the infor-
mation that a diagnosis provides might also discourage
physicians from dismissing memory complaints and in-
crease the likelihood that they would intervene.9,37,38
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